An outbreak of opportunity

Chynoweth, Emma; Baker, John
February 2007
ICIS Chemical Business;2/12/2007, Vol. 2 Issue 53, p24
Trade Publication
The article reports on the search of Indian companies for additional expansion opportunities in the pharmaceutical and fine chemical mergers and acquisitions. According to Habil Khorakiwala, chairman of Wockhardt, India has a wonderful combination of scientific skills, dynamic private enterprise and large, integrated competitive manufacturing infrastructure, which gives it an edge in the global generic pharmaceutical market. Contract manufacturing players that present additional acquisition opportunities are cited.


Related Articles

  • Wockhardt setting up plant in Chandigarh.  // Chemical Business;Jul95, Vol. 8 Issue 12, p89 

    Reports on Wockhardt's establishment of a pharmaceutical production facility in Chandigarh, India. Total cost; Targeted date of completion; Comment from chairman Habil F. Khorakiwala.

  • The Care in Healthcare: Zahabiya Khorakiwala.  // India Today;3/12/2012, p22 

    The article focuses on the career highlights of Zahabiya Khorakiwala, legacy daughter of Wockhardt Group chairman Habil Khorakiwala in Mumbai, India.

  • Wockhardt to Toe US FDA Line on Shendra Unit.  // Medical Buyer;1/29/2016, p1 

    The article focuses on the need for drug maker Wockhardt to comply with all the observations of the U.S. Food and Drug Administration regarding the company's Shendra unit, according to chairman Habil Khorakiwala.

  • TURBULENT WATERS. Young, Peter // Pharmaceutical Representative;Dec2011, Vol. 41 Issue 12, p12 

    The article focuses on the continued merger and acquisition in the pharmaceutical industry in the U.S. It notes that merger and acquisitions by pharmaceutical companies has continued and became stronger from 2010 to the first half of 2011. Such development was driven by companies' goals to fill...

  • STOCKWATCH.  // Dow Theory Forecasts;6/18/2001, Vol. 57 Issue 25, p2 

    Reports stock market developments as of June 2001. Presentation of the earnings and finances of several companies; Acquisitions and alliances; Information concerning the pharmaceutical industries.

  • Millennium ends Takeda's US shopping spree. Sipp, Douglas // Nature Biotechnology;Jun2008, Vol. 26 Issue 6, p593 

    This article discusses Japan's Takeda Pharmaceutical's acquisition of Millennium Pharmaceuticals of Cambridge, Massachusetts. The purchase is one of several American companies bought by Japanese pharmaceutical companies. The Takeda deal is the largest acquisition of a foreign firm by the...

  • Indian generics companies go on spending spree. Jayaraman, K. S. // Nature Reviews Drug Discovery;Aug2005, Vol. 4 Issue 8, p616 

    Reports on the global expansion of India-based generic drugs companies through the acquisition of international companies. Pressures on Indian companies to expand beyond the domestic market; Reasons for the growth in Indian drug firms' international acquisition activity.

  • Takeda Set To Purchase A Vaccine Developer.  // Chain Drug Review;6/3/2013, Vol. 35 Issue 9, p49 

    The article offers pharmaceutical industry news briefs as of June 3, 2013 including sale of the biopharmaceutical company Inviragen Inc., acquisition of Xellia Pharmaceuticals AS and the National Community Pharmacists Association's support for a bipartisan legislation to help Medicare beneficiaries.

  • Salud Dorada sold for $4 million. Rosa, Taína // Caribbean Business;10/5/2006, Vol. 34 Issue 39, p7 

    The article reports on the sale of Medicare Advantage plan Salud Dorada con Medicare to a group of physicians for $4 million, according to Jorge Méndez, one of the physicians involved in the transaction in Puerto Rico. Méndez said that the two groups will merge and operate under Salud...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics